Characterization and molecular profiling of PSEN1 familial Alzheimer's disease iPSC-derived neural progenitors.
about
Modeling Alzheimer's Disease with Induced Pluripotent Stem Cells: Current Challenges and Future ConcernsInduced pluripotent stem cells in Alzheimer's disease: applications for disease modeling and cell-replacement therapyThe Application of Human iPSCs in Neurological Diseases: From Bench to BedsideAlzheimer's in 3D culture: challenges and perspectivesAdvances in Stem Cell Research- A Ray of Hope in Better Diagnosis and Prognosis in Neurodegenerative Diseases3D culture models of Alzheimer's disease: a road map to a "cure-in-a-dish"Towards Personalized Intervention for Alzheimer's DiseaseBMS-708163 and Nilotinib restore synaptic dysfunction in human embryonic stem cell-derived Alzheimer's disease modelsStem cell models of Alzheimer's disease: progress and challenges.Characterization of a subpopulation of developing cortical interneurons from human iPSCs within serum-free embryoid bodiesProbing the secrets of Alzheimer's disease using human-induced pluripotent stem cell technology.A time course analysis of the electrophysiological properties of neurons differentiated from human induced pluripotent stem cells (iPSCs).Probing disorders of the nervous system using reprogramming approaches.A 3D human neural cell culture system for modeling Alzheimer's disease.Dysregulation of Nutrient Sensing and CLEARance in Presenilin Deficiency.Alterations in mitochondrial number and function in Alzheimer's disease fibroblastsRecapitulating amyloid β and tau pathology in human neural cell culture models: clinical implications.Alzheimer disease research in the 21st century: past and current failures, new perspectives and funding prioritiesEarly pathogenic event of Alzheimer's disease documented in iPSCs from patients with PSEN1 mutations.Human-induced pluripotent stem cells: potential for neurodegenerative diseases.Human stem cell models of dementia.The potential of induced pluripotent stem cells in models of neurological disorders: implications on future therapy.Induced Pluripotent Stem Cells Derived from Alzheimer's Disease Patients: The Promise, the Hope and the Path Ahead.Induced pluripotent stem cells as a discovery tool for Alzheimer׳s disease.Back and forth in time: Directing age in iPSC-derived lineages.Modeling Alzheimer's disease with human induced pluripotent stem (iPS) cells.Mitophagy Failure in Fibroblasts and iPSC-Derived Neurons of Alzheimer's Disease-Associated Presenilin 1 Mutation.A three-dimensional human neural cell culture model of Alzheimer's disease.CRISPR/Cas9-Correctable mutation-related molecular and physiological phenotypes in iPSC-derived Alzheimer's PSEN2 N141I neurons.Changes in the detergent-insoluble brain proteome linked to amyloid and tau in Alzheimer's Disease progression.Human Induced Pluripotent Stem Cells and the Modelling of Alzheimer's Disease: The Human Brain Outside the Dish.Neurons derived from sporadic Alzheimer's disease iPSCs reveal elevated TAU hyperphosphorylation, increased amyloid levels, and GSK3B activation.3D Miniaturization of Human Organs for Drug Discovery.Stem Cell Technology for (Epi)genetic Brain Disorders.Human Neurospheroid Arrays for In Vitro Studies of Alzheimer's Disease.Developing HiPSC Derived Serum Free Embryoid Bodies for the Interrogation of 3-D Stem Cell Cultures Using Physiologically Relevant Assays.Efficient introduction of specific homozygous and heterozygous mutations using CRISPR/Cas9.Genome-editing applications of CRISPR-Cas9 to promote in vitro studies of Alzheimer's disease.Representing Diversity in the Dish: Using Patient-Derived in Vitro Models to Recreate the Heterogeneity of Neurological Disease.Neurons Derived from Induced Pluripotent Stem Cells of Patients with Down Syndrome Reproduce Early Stages of Alzheimer's Disease Type Pathology in vitro.
P2860
Q54741044-EB9E0DB8-2DA1-4E0A-92D4-DE523AE85B35Q54741152-61FFE32B-B3E1-4B5B-A1A1-84C862C442F8Q54741991-823B4BF0-B512-4FA2-8D5C-11D1E0FDD79FQ54931384-5A7B555D-60D0-4094-BBC9-BC3BB1979FF1Q54931385-CD1A163B-9860-4A7E-81F3-D0FE0BB4BDCDQ54931386-B5C37137-2DB2-4BDC-826C-C81EF26D1CC4Q54931387-3F039FD1-4401-47BE-BA6C-8FCD46814A00Q54931388-5E8D98DC-0856-4993-AD8D-7FD74C634C10
P1343
Q26745513-E9E4598E-79E8-4F96-80FF-8C7DA508A21EQ26749360-376C4C87-D5C6-4D7E-B48C-7E774C6075C1Q26765876-4FC80019-1898-48A8-BA03-4CC72C70A1B0Q26801081-1F808479-A30A-4D87-91B9-F1DA6117D5B7Q28067160-ED99B83A-C54A-4726-9153-D5650D11204CQ28078900-D827C7D7-548E-4B04-9B07-EF78E07D0182Q28080098-BCA941E3-2BE6-432B-8552-A87280354C6CQ28829902-CA85FE43-8759-43FB-A814-6491FDF4162DQ33796378-2A9C1202-4456-434E-AEE6-29A2E0F434F5Q35034834-C16FA3B6-5B7D-40EA-A6F8-07FDD35C9147Q35064977-EA4FE81E-8CEF-4DA9-ADB2-ED2DCB0E4F13Q35214817-275EF9D5-FF19-4E78-9C08-8CDC733847F6Q35761135-1E6A8349-5CFC-4914-A533-F7F0B18537A7Q35842312-82E7CB48-EA82-4152-993A-4E2A4FE22336Q36690758-9FBC91F4-A56A-45AD-8008-0EBBA7D90A32Q36709696-64BBD832-FF1C-484A-8354-9AA4A433C21DQ36715710-6659F7DE-C6DF-43D6-9304-FC689C61289DQ37457369-EECE9122-AB2D-4802-B63F-588694D3A800Q37702630-9935A167-93F9-4366-8CB6-7DAA2F71DF94Q38211497-16052137-9D16-46AC-9B48-84CE8CEDC327Q38221121-878C4DC1-2941-456B-B423-B2F6886014BCQ38349063-C8AB4AF6-18E8-4DD7-B149-773CF2482358Q38559734-4085ACE6-E9BB-40A3-B60B-6585ACBC3931Q38605546-C663CCBF-B580-41D2-9700-693854DC2E88Q38642565-8DF5A87C-09BD-4E59-ABF7-B549751ACC3CQ38666481-B32C6A20-7CA8-4910-BD8E-197C82443AA8Q41673213-B4835040-1971-427A-B0FF-1CCEEE121C4FQ42069680-2B9B8E7F-D48A-40E7-A120-12659AAB3F5FQ42517607-E2DC2C58-F610-450C-817E-03B3D755F73BQ44921042-B6A24D8E-575A-42B8-982C-33FB44260BC3Q47124444-E73204A0-71F2-46D1-A2BA-D4E5DF76B64BQ47345806-C6E9CF01-41FB-4748-A2C3-4F2A5A103EA7Q47698887-0873559E-3B73-465A-9479-8AA419DAB6FFQ47718746-5BA308B9-1D19-4B40-865C-0364A3122414Q48102996-11823821-B313-40BD-88C6-36EA70A70063Q48163128-B15BCE11-7DED-4CCC-94E1-0AD3507C312CQ48789186-31D2F0D6-AED9-45FB-8EC0-9E0E78417349Q49478512-286B9A69-2D9E-4D3D-BAD5-E2AD06A9AB8DQ50322422-29A6D05F-C239-4B87-972C-527E32451DFEQ50463961-F61F89D4-0135-4FE3-BF22-80E588F75971
P2860
Characterization and molecular profiling of PSEN1 familial Alzheimer's disease iPSC-derived neural progenitors.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Characterization and molecular ...... SC-derived neural progenitors.
@en
Characterization and molecular ...... SC-derived neural progenitors.
@nl
type
label
Characterization and molecular ...... SC-derived neural progenitors.
@en
Characterization and molecular ...... SC-derived neural progenitors.
@nl
prefLabel
Characterization and molecular ...... SC-derived neural progenitors.
@en
Characterization and molecular ...... SC-derived neural progenitors.
@nl
P2093
P2860
P4510
P1433
P1476
Characterization and molecular ...... SC-derived neural progenitors.
@en
P2093
Alex Dranovsky
David J Kahler
Deborah Pre
Ismael Santa-Maria
John F Crary
John W Steele
Matthew Zimmer
Michael W Nestor
Miriam Navarro-Sobrino
P2860
P304
P356
10.1371/JOURNAL.PONE.0084547
P407
P4510
P577
2014-01-08T00:00:00Z